219 related articles for article (PubMed ID: 23717036)
1. Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension.
Lanzl I; Hamacher T; Rosbach K; Ramez MO; Rothe R; Růžičková E; Karhanová M; Kimmich F
Clin Ophthalmol; 2013; 7():901-10. PubMed ID: 23717036
[TBL] [Abstract][Full Text] [Related]
2. Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension.
Erb C; Lanzl I; Seidova SF; Kimmich F
Adv Ther; 2011 Jul; 28(7):575-85. PubMed ID: 21725844
[TBL] [Abstract][Full Text] [Related]
3. IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma.
Hommer A; Mohammed Ramez O; Burchert M; Kimmich F
Curr Med Res Opin; 2010 Aug; 26(8):1905-13. PubMed ID: 20553122
[TBL] [Abstract][Full Text] [Related]
4. Preservative-Free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% for Treatment-Naive Patients with Open-Angle Glaucoma.
Rhee T; Kim J; Ha A
Korean J Ophthalmol; 2024 Jun; 38(3):221-226. PubMed ID: 38665112
[TBL] [Abstract][Full Text] [Related]
5. A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components.
Pfeiffer N; Traverso CE; Lorenz K; Saarela V; Liinamaa J; Uusitalo H; Astakhov Y; Boiko E; Ropo A;
Adv Ther; 2014 Dec; 31(12):1228-46. PubMed ID: 25447269
[TBL] [Abstract][Full Text] [Related]
6. Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study.
Pillunat LE; Erb C; Ropo A; Kimmich F; Pfeiffer N
Clin Ophthalmol; 2017; 11():1051-1064. PubMed ID: 28652689
[TBL] [Abstract][Full Text] [Related]
7. Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost.
Hommer A; Kimmich F
Clin Ophthalmol; 2011; 5():623-31. PubMed ID: 21629567
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy.
Oddone F; Scorcia V; Iester M; Sisto D; De Cilla S; Bettin P; Cagini C; Figus M; Marchini G; Rossetti L; Rossi G; Salgarello T; Scuderi GL; Staurenghi G;
Clin Ophthalmol; 2022; 16():1707-1719. PubMed ID: 35677639
[TBL] [Abstract][Full Text] [Related]
9. [Preservative-free fixed combination in the treatment of open-angle glaucoma and ocular hypertension: the VISIONARY Study (EUPAS22204)].
Karlova EV; Petrov SY; Germanova VN
Vestn Oftalmol; 2020; 136(4):76-84. PubMed ID: 32779459
[TBL] [Abstract][Full Text] [Related]
10. Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma.
Janulevičienė I; Derkač I; Grybauskiene L; Paulauskaitė R; Gromnickaite R; Kuzmienė L
Clin Ophthalmol; 2012; 6():103-9. PubMed ID: 22275814
[TBL] [Abstract][Full Text] [Related]
11. Prospective observational post-marketing study of tafluprost for glaucoma and ocular hypertension: short-term efficacy and safety.
Kuwayama Y; Nomura A
Adv Ther; 2014 Apr; 31(4):461-71. PubMed ID: 24615289
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China.
Sun X; Liu Q; Tang X; Yao K; Li Y; Yang J; Zhang M; Yuan H; Zheng Y; Li W; Peng H
BMC Ophthalmol; 2022 Aug; 22(1):332. PubMed ID: 35932001
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of preserved Tafluprost 0.0015% in lowering intraocular pressure.
Paul C
Indian J Ophthalmol; 2023 Dec; 71(12):3652-3657. PubMed ID: 37991299
[TBL] [Abstract][Full Text] [Related]
14. 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy.
Konstas AG; Boboridis KG; Kapis P; Marinopoulos K; Voudouragkaki IC; Panayiotou D; Mikropoulos DG; Pagkalidou E; Haidich AB; Katsanos A; Quaranta L
Adv Ther; 2017 Jan; 34(1):221-235. PubMed ID: 27913991
[TBL] [Abstract][Full Text] [Related]
15. Twenty-four-hour efficacy of preservative-free tafluprost for open-angle glaucoma patients, assessed by home intraocular pressure (Icare-ONE) and blood-pressure monitoring.
Cho SY; Kim YY; Yoo C; Lee TE
Jpn J Ophthalmol; 2016 Jan; 60(1):27-34. PubMed ID: 26411460
[TBL] [Abstract][Full Text] [Related]
16. Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence.
Kuwayama Y; Hashimoto M; Kakegawa R; Nomura A; Shimada F
Adv Ther; 2017 Jun; 34(6):1411-1425. PubMed ID: 28502035
[TBL] [Abstract][Full Text] [Related]
17. First-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressure.
Denis P; Baudouin C; Bron A; Nordmann JP; Renard JP; Rouland JF; Sellem E; Amrane M
BMC Ophthalmol; 2010 Feb; 10():4. PubMed ID: 20181282
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Ocular Pulse Amplitude Lowering Effects of Preservative-Free Tafluprost and Preservative-Free Dorzolamide-Timolol Fixed Combination Eyedrops.
Seo du R; Ha SJ
Biomed Res Int; 2015; 2015():435874. PubMed ID: 26557671
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension.
Konstas AG; Quaranta L; Katsanos A; Riva I; Tsai JC; Giannopoulos T; Voudouragkaki IC; Paschalinou E; Floriani I; Haidich AB
Br J Ophthalmol; 2013 Dec; 97(12):1510-5. PubMed ID: 23681371
[TBL] [Abstract][Full Text] [Related]
20. Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension.
Hoy SM
Drugs; 2015 Oct; 75(15):1807-13. PubMed ID: 26431840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
